TY - JOUR
T1 - Response to an exercise intervention after endometrial cancer
T2 - Differences between obese and non-obese survivors
AU - Basen-Engquist, K.
AU - Carmack, C.
AU - Brown, J.
AU - Jhingran, A.
AU - Baum, G.
AU - Song, J.
AU - Scruggs, S.
AU - Swartz, M. C.
AU - Cox, M. G.
AU - Lu, K. H.
PY - 2014/4
Y1 - 2014/4
N2 - Objective The objective of this paper is to describe baseline differences between obese and non-obese endometrial cancer survivor in anthropometrics, exercise behavior, fitness, heart rate and blood pressure, and quality of life, and to analyze whether the effect of a home-based exercise intervention on these outcomes differed for obese and non-obese participants. Methods One hundred post-treatment Stage I-IIIa endometrial cancer survivors participated in a single arm 6 month study in which they received a home-based exercise intervention. Cardiorespiratory fitness, anthropometrics, and exercise behavior were measured every two months, and quality of life (QOL) and psychological distress were measured at baseline and 6 months. Results Adjusting for potential confounders, at baseline obese survivors had poorer cardiorespiratory fitness (p =.002), higher systolic blood pressure (p =.018), and lower physical functioning (p <.001) and ratings of general health (p =.002), and more pain (p =.037) and somatization (.002). Significant improvements were seen in exercise behavior, resting heart rate, systolic blood pressure, and multiple QOL domains over the course of the intervention. Obese survivors had less improvement in exercise behavior and cardiorespiratory fitness than non-obese survivors, but there were no differences with regard to improvements in QOL and stress. Conclusions Home based exercise interventions are beneficial to endometrial cancer survivors, including those whose BMI is in the obese range. While obese survivors have lower levels of physical activity and fitness, they experienced similar activity, fitness, quality of life and mental health benefits. Exercise should be encouraged in endometrial cancer survivors, including those who are obese.
AB - Objective The objective of this paper is to describe baseline differences between obese and non-obese endometrial cancer survivor in anthropometrics, exercise behavior, fitness, heart rate and blood pressure, and quality of life, and to analyze whether the effect of a home-based exercise intervention on these outcomes differed for obese and non-obese participants. Methods One hundred post-treatment Stage I-IIIa endometrial cancer survivors participated in a single arm 6 month study in which they received a home-based exercise intervention. Cardiorespiratory fitness, anthropometrics, and exercise behavior were measured every two months, and quality of life (QOL) and psychological distress were measured at baseline and 6 months. Results Adjusting for potential confounders, at baseline obese survivors had poorer cardiorespiratory fitness (p =.002), higher systolic blood pressure (p =.018), and lower physical functioning (p <.001) and ratings of general health (p =.002), and more pain (p =.037) and somatization (.002). Significant improvements were seen in exercise behavior, resting heart rate, systolic blood pressure, and multiple QOL domains over the course of the intervention. Obese survivors had less improvement in exercise behavior and cardiorespiratory fitness than non-obese survivors, but there were no differences with regard to improvements in QOL and stress. Conclusions Home based exercise interventions are beneficial to endometrial cancer survivors, including those whose BMI is in the obese range. While obese survivors have lower levels of physical activity and fitness, they experienced similar activity, fitness, quality of life and mental health benefits. Exercise should be encouraged in endometrial cancer survivors, including those who are obese.
KW - Cardiorespiratory fitness
KW - Endometrial cancer
KW - Exercise
KW - Intervention
KW - Obesity
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=84897045075&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897045075&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2014.01.025
DO - 10.1016/j.ygyno.2014.01.025
M3 - Article
C2 - 24680591
AN - SCOPUS:84897045075
SN - 0090-8258
VL - 133
SP - 48
EP - 55
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 1
ER -